EUVIMEDOpdag EUVIMED
Crossref

DNA Flow Cytometry Analysis in Body Cavity Fluids Using Liquid‐Based Cytology

Ayumi Ryu iD, Keiichiro Honma iD, Sayoko Tsuzaki, Risa Yoshioka, Satoshi Tanada, Takashi Yamamoto, Hidetoshi Satomi iD, Shigenori Nagata iD, Tomoyuki Yamasaki, Masayuki Ohue iD

Diagnostic Cytopathology · 2025

DOI: 10.1002/dc.25451 ↗

At a glance

Journal article in Diagnostic Cytopathology, 2025. Written by Ayumi Ryu and 9 co-authors. Institution: Department of Clinical Laboratory, Osaka International Cancer Institute, Osaka, Japan. Major MEDLINE topics: Flow Cytometry, Body Fluids, Cytodiagnosis, DNA. 36 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

DNA flow cytometry using LC‐1000 is utilized for analyzing cellular and nuclear lengths and DNA content in individual cells with samples in cell preservation solutions to acquire the cell proliferation index (CPIx). This study aimed to evaluate the performance of body cavity fluid cytology using LC‐1000. As cell preservation solutions, liquid‐based cytology (LBC) by Cellprep (CP) was compared with CelVerse (CeV), specifically designed for the LC‐1000.

Methods

Overall, we evaluated 43 samples (20 malignant and 23 benign) of body cavity fluids suspended in CeV and 59 samples (28 malignant and 31 benign) suspended in CP. The CPIx was compared between malignant and benign cases of CeV and CP. Further, the subject groups were divided according to the SubG1% in a sample.

Results

The CPIx in CeV was 0.14–10.22 (median 0.62) in malignant cases and 0.09–4.64 (median 0.19) in benign cases ( p < 0.001); additionally, CP displayed 0.14–9.87 (median 0.84) in malignant cases and 0.11–3.02 (median 0.22) in benign cases ( p < 0.001). The area under the curve (AUC) was 0.811 for CeV and 0.776 for CP. The difference in SubG1% between the CeV and CP groups was statistically significant ( p < 0.0001) and influenced the AUC in CP.

Conclusion

The CPIx in CeV or CP samples using the LC‐1000 may be applicable as an objective indicator in body cavity fluid cytology. Samples preserved in CeV provided more consistent results, unaffected by SubG1%, when compared to those stored in CP.

Subjects

MeSH terms (MEDLINE)

Flow CytometryBody FluidsCytodiagnosisDNANeoplasmsHumansFemaleMaleMiddle AgedAgedAdultAged, 80 and over

Author keywords

DNAbody cavity fluidsflow cytometryliquid‐based cytology

Substances

DNA

Authors and institutions

  • Department of Clinical Laboratory, Osaka International Cancer Institute, Osaka, Japan.
  • Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan.
  • Department of Oncology, Graduate School of Medicine, Osaka University, Osaka, Japan.

ORCID profiles: Ayumi Ryu, Keiichiro Honma, Hidetoshi Satomi, Shigenori Nagata, Masayuki Ohue

Cite

APA

Ryu, A., Honma, K., Tsuzaki, S., Yoshioka, R., Tanada, S., Yamamoto, T., Satomi, H., Nagata, S., Yamasaki, T., & Ohue, M. (2025). DNA Flow Cytometry Analysis in Body Cavity Fluids Using Liquid‐Based Cytology. Diagnostic Cytopathology. https://doi.org/10.1002/dc.25451

Vancouver

Ryu A, Honma K, Tsuzaki S, Yoshioka R, Tanada S, Yamamoto T, et al. DNA Flow Cytometry Analysis in Body Cavity Fluids Using Liquid‐Based Cytology. Diagnostic Cytopathology. 2025. doi:10.1002/dc.25451

BibTeX
@article{Ryu2025,
  author = {Ryu, Ayumi and Honma, Keiichiro and Tsuzaki, Sayoko and Yoshioka, Risa and Tanada, Satoshi and Yamamoto, Takashi and Satomi, Hidetoshi and Nagata, Shigenori and Yamasaki, Tomoyuki and Ohue, Masayuki},
  title = {DNA Flow Cytometry Analysis in Body Cavity Fluids Using Liquid‐Based Cytology},
  journal = {Diagnostic Cytopathology},
  year = {2025},
  doi = {10.1002/dc.25451}
}
Start for free →